Artelo Biosciences, Inc. (ARTL) vs Clearmind Medicine Inc. (CMND)

Artelo Biosciences, Inc. and Clearmind Medicine Inc. are both Biotechnology companies. Artelo Biosciences, Inc. and Clearmind Medicine Inc. are of similar size ($2.8M and $2.7M). Across the 11 metrics below, Clearmind Medicine Inc. leads on 7 and Artelo Biosciences, Inc. on 4.

Valuation

Metric ARTL CMND Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.27 0.10 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.26 1.46 0.74
EV/Sales n/m n/m 10.73
Earnings yield (2,586.13%) (11,553.20%) (28.84%)
Free cash flow yield (923.67%) (558.57%) (23.03%)

Profitability

Metric ARTL CMND Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (705.71%) (106.98%) (57.72%)
Return on assets (234.30%) (71.81%) (49.22%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL CMND Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 31.57% 55.10% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL CMND Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 3.00 4.31 4.73
Net debt to EBITDA 0.05 0.68 0.96

Dividend

Metric ARTL CMND Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric ARTL CMND Biotechnology median
Market cap 2.71m 2.83m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack